Cryo-Cell International (NYSEAMERICAN:CCEL) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.11 and traded as low as $3.30. Cryo-Cell International shares last traded at $3.33, with a volume of 14,963 shares.

Cryo-Cell International Trading Down 0.3%

The firm has a market cap of $26.84 million, a P/E ratio of -47.56 and a beta of 0.59. The business’s fifty day simple moving average is $3.47 and its 200-day simple moving average is $4.11.

Institutional Trading of Cryo-Cell International

A hedge fund recently bought a new stake in Cryo-Cell International stock. Susquehanna International Group LLP bought a new position in Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 11,062 shares of the company’s stock, valued at approximately $51,000. Susquehanna International Group LLP owned 0.14% of Cryo-Cell International as of its most recent SEC filing. 10.44% of the stock is owned by institutional investors and hedge funds.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc is a pioneering provider of umbilical cord blood and tissue preservation services. Headquartered in Oldsmar, Florida, the company was founded in 1989 as the first private cord blood bank in the United States. Cryo-Cell operates FDA-registered and AABB-accredited laboratory facilities, maintaining stringent quality control measures and cryogenic storage systems to safeguard stem cell viability over long-term storage periods.

The company’s primary business activity centers on the collection, processing and secure storage of newborn stem cell sources harvested at birth.